Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-06-06T21:53:53.426Z Has data issue: false hasContentIssue false

Section VI - Vaginal and Vulvar Cancer

Published online by Cambridge University Press:  20 July 2023

Edited by
Dennis S. Chi ,
Nisha Lakhi  and
Nicoletta Colombo
Dennis S. Chi
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York
Nisha Lakhi
Affiliation:
Richmond University Medical Center, Staten Island
Nicoletta Colombo
Affiliation:
University of Milan-Bicocca
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
50 Big Debates in Gynecologic Oncology , pp. 291 - 312
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Van der Zee AGJ, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884–889.CrossRefGoogle Scholar
Levenback, CF, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. J Clin Oncol 2012;30:3786–3791.CrossRefGoogle ScholarPubMed
Stehman, FB, et al. Groin dissection vs groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Rad Oncol Biol Phys 1992;24:389–396.CrossRefGoogle Scholar
Oonk, MHM, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early-stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646–652.CrossRefGoogle ScholarPubMed
Oonk, MHM, et al. Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II. Int J Gynecol Cancer 2019;29(Suppl. 4):A14.Google Scholar

References

American Cancer Society. Cancer Facts & Figures 2022. Atlanta, GA: American Cancer Society, 2022.Google Scholar
Van der Zee, AG, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26(6):884–889.CrossRefGoogle ScholarPubMed
Te Grootenhuis, NC, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016;140(1):8–14.CrossRefGoogle Scholar
Levenback, CF, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. J Clin Oncol 2012;30(31):3786–3791.CrossRefGoogle ScholarPubMed
Oonk, MHM, et al. Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II. J Clin Oncol 2021;39(32):3623–3632.CrossRefGoogle ScholarPubMed
Glaser, S, et al. Inguinal nodal radiotherapy for vulvar cancer: are we missing the target again? Gynecol Oncol 2014;135(3):583–585.CrossRefGoogle Scholar
Montana, GS, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 2000;48(4):1007–1013.CrossRefGoogle ScholarPubMed

References

Stehman, F, et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992;79(4):490–497.Google Scholar
Heaps, JM, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38(3):309–314. https://doi.org/10.1016/0090-8258(90)90064-RCrossRefGoogle ScholarPubMed
Arvas, M, et al. The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2018;28:623–631.CrossRefGoogle ScholarPubMed
Bradley, K, et al. (Squamous Cell Carcinoma) Vulvar Cancer. 2020.Google Scholar
Bedell, SM, et al. Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins. Gynecol Oncol 2019;154(2):276–279. https://doi.org/10.1016/j.ygyno.2019.05.028CrossRefGoogle ScholarPubMed
Ioffe, YJ, et al. Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins. Gynecol Oncol 2013;129(3):528–532. https://doi.org/10.1016/j.ygyno.2013.02.033CrossRefGoogle ScholarPubMed
Faul, CM, et al. Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 1997;38(2):381–389. https://doi.org/10.1016/S0360-3016(97)82500-XCrossRefGoogle ScholarPubMed
Gaarenstroom, KN, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003;13(4):522–527. https://doi.org/10.1046/j.1525-1438.2003.13304.xCrossRefGoogle ScholarPubMed

References

SEER Database: Vulvar Cancer. Available from: https://seer.cancer.gov/statfacts/html/vulva.html [last accessed November 9, 2022].Google Scholar
Heaps, JM, et al. Surgical pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38 (3):309.CrossRefGoogle ScholarPubMed
Ignatov, T, et al. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 2016;142:489–495.CrossRefGoogle ScholarPubMed
Alimena, S, et al. Patient reported outcome measures among patients with vulvar cancer at various stages of treatment, recurrence and survivorship. Gynecol Oncol 2021;160:252–259.Google ScholarPubMed
Grootenhuis, NC, et al. Margin status revisited in vulvar squamous cell carcinoma. Gynecol Oncol 2019;154(2):266–275.CrossRefGoogle Scholar

References

Hacker, NF, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63(2):155.Google Scholar
National Comprehensive Cancer Network. NCCN guidelines. Available from: www.nccn.org/professionals/physician_gls/pdf/vulvar.pdfGoogle Scholar
Mahner, S, et al. Adjuvant therapy in lymph node positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015;107(3):dju426.CrossRefGoogle ScholarPubMed
Parthasarathy, A, et al. The benefit of adjuvant radiation therapy in single node positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103:1095–1099.CrossRefGoogle ScholarPubMed

References

Woelber, L, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22(3):503–508.CrossRefGoogle ScholarPubMed
Homesley, HD, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68(6):733–740.Google ScholarPubMed
Mahner, S, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015;107(3):dju426.CrossRefGoogle ScholarPubMed
Fons, G, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 2009;114(2):343–345.CrossRefGoogle Scholar
Parthasarathy, A, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103(3):1095–1099.CrossRefGoogle ScholarPubMed

References

Boer, FL, et al. Vulvar malignant melanoma: pathogenesis, clinical behaviour and management: review of the literature. Cancer Treat Rev 2019;73:91–103.CrossRefGoogle ScholarPubMed
Saito, T, et al. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. Int J Clin Oncol 2018;23:201–234.CrossRefGoogle Scholar
Mert, I, et al. Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities. Int J Gynecol Cancer 2013;23:1118–1125.CrossRefGoogle ScholarPubMed
Geisler, JP, et al. Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion. Gynecol Oncol 1995;59:338–341.CrossRefGoogle ScholarPubMed
Frumovitz, M, et al. Primary malignant melanoma of the vagina. Obstet Gynecol 2010;116:1358–1365.CrossRefGoogle ScholarPubMed
Look, KY, et al. Vulvar melanoma reconsidered. Cancer 1993;72:143–146.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Agrawal, S, et al. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer 2009;115:5836–5844.CrossRefGoogle ScholarPubMed
Xing, Y, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst 2011;103:129–142.CrossRefGoogle ScholarPubMed
Rezk, YA, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol 2013;128:191–197.CrossRefGoogle ScholarPubMed
Schneider, A, et al. Current developments for pelvic exenteration in gynecologic oncology. Curr Opin Obstet Gynecol 2009;21:4–9.CrossRefGoogle ScholarPubMed

References

Mert, I, et al. Vulvar/vaginal melanoma: an updated Surveillance Epidemiology and End Results Database review, comparison with cutaneous melanoma and significance of racial disparities. Int J Gynecol Cancer 2013;23:1118–1125.CrossRefGoogle ScholarPubMed
Schiavone, MB, et al. Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract. Gynecol Oncol Rep 2016;16:42–46.CrossRefGoogle ScholarPubMed
Salama, AKS, et al. Ipilimumab and radiation in patients with high risk resected or regionally advanced melanoma. Clin Cancer Res 2021;27(5):1287–1295.CrossRefGoogle ScholarPubMed
National Comprehensive Cancer Network. Melanoma: cutaneous (Version 1.2021). Available from: www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdfGoogle Scholar
Dummer, R, et al. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicenter, open-label, randomized, phase 3 trial. Lancet Oncol 2018;19:1315–1327.CrossRefGoogle ScholarPubMed
Wasif, N, et al. Does metastatectomy improve survival in patients with stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol 2011;104:111–115.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×